White House officials on Wednesday are expected to outline steps the administration has taken to try to speed up the availability and access to Covid-19 treatments such as antivirals that have been in short supply amid a surge of cases of the Omicron variant.
The drugs, including Pfizer Inc.’s Paxlovid, are expected to play a critical role keeping people out of hospitals, but are in limited supply.